Vagus nerve contributes to metabolic syndrome in high-fat diet-fed young and adult rats

Experimental Physiology

Volumn 100, Issue 1, 2015, Pages 57-68

  Barella, Luiz F ^a   Miranda, Rosiane A ^a   Franco, Claudinéia C S ^a   Alves, Vander S ^a   Malta, Ananda ^a   Ribeiro, Tatiane A S ^a   Gravena, Clarice ^a   Mathias, Paulo C F ^a   de Oliveira, Júlio C ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN;

AGE; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOPHYSIOLOGY; SURGERY; TIME; VAGOTOMY; VAGUS NERVE; WEANING; WEIGHT GAIN; WISTAR RAT;

ADIPOSITY; AGE FACTORS; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; INSULIN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; RATS, WISTAR; TIME FACTORS; VAGOTOMY; VAGUS NERVE; WEANING; WEIGHT GAIN;

EID: 84925353860     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EXPPHYSIOL.2014.082982     Document Type: Article

References (48)

1. Ahrén B (2000). Autonomic regulation of islet hormone secretion – implications for health and disease. Diabetologia 43, 393–410.
2. Angelini N, Rafacho A, Boschero AC & Bosqueiro JR (2010). Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats. Diabetes Res Clin Pract 87, 184–191.
3. Balbo SL, Bonfleur ML, Carneiro EM, Amaral ME, Filiputti E & Mathias PC (2002). Parasympathetic activity changes insulin response to glucose and neurotransmitters. Diabetes Metab 28, 3S13–3S17; discussion 3S108–3S112.
4. Balbo SL, Grassiolli S, Ribeiro RA, Bonfleur ML, Gravena C, Brito Mdo N, Andreazzi AE, Mathias PC & Torrezan R (2007). Fat storage is partially dependent on vagal activity and insulin secretion of hypothalamic obese rat. Endocrine 31, 142–148.
5. Balbo SL, Mathias PC, Bonfleur ML, Alves HF, Siroti FJ, Monteiro OG, Ribeiro FB & Souza AC (2000). Vagotomy reduces obesity in MSG-treated rats. Res Commun Mol Pathol Pharmacol 108, 291–296.
6. Barella LF, de Oliveira JC, Branco RC, Camargo RL, Gomes RM, Mendes FC, Miranda RA, Gravena C, Torrezan R, Grassiolli S & de Freitas Mathias PC (2012). Early exposure to a high-fat diet has more drastic consequences on metabolism compared with exposure during adulthood in rats. Horm Metab Res 44, 458–464.
7. Bateson P, Barker D, Clutton-Brock T, Deb D, D’Udine B, Foley RA, Gluckman P, Godfrey K, Kirkwood T, Lahr MM, McNamara J, Metcalfe NB, Monaghan P, Spencer HG & Sultan SE (2004). Developmental plasticity and human health. Nature 430, 419–421.
8. Bergmeyer HU & Gawehn K (1974). Methods of Enzymatic Analysis. Verlag Chemie, Weinheim; Academic Press, New York.
9. Bernardis LL & Patterson BD (1968). Correlation between ‘Lee index’ and carcass fat content in weanling and adults female rats with hypothalamic lesions. J Endocrinol 40, 527–528.
10. Bernstein IL & Goehler LE (1983). Vagotomy produces learned food aversions in the rat. Behav Neurosci 97, 585–594.
11. Borst SE & Conover CF (2005). High-fat diet induces increased tissue expression of TNF-α. Life Sci 77, 2156–2165.
12. Bray GA (1991). Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis. J Nutr 121, 1146– 1162.
13. Bray GA & York DA (1979). Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59, 719–809.
14. Chen NG, Tassava TM & Romsos DR (1993). Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low. J Nutr 123, 1567–1574.
15. Cox JE & Powley TL (1981). Prior vagotomy blocks VMH obesity in pair-fed rats. Am J Physiol Endocrinol Metab 240, E573–E583.
16. Davy KP & Orr JS (2009). Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev 33, 116–124.
17. de Oliveira JC, Scomparin DX, Andreazzi AE, Branco RC, Martins AG, Gravena C, Grassiolli S, Rinaldi W, Barbosa FB & Mathias PC (2011). Metabolic imprinting by maternal protein malnourishment impairs vagal activity in adult rats. J Neuroendocrinol 23, 148–157.
18. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ & Velloso LA (2005). Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146, 4192–4199.
19. Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A & McGarry JD (2002). The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 51, 1825–1833.
20. Dyck DJ (2009). Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 34, 396–402.
21. Edvell A & Lindström P (1998). Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am J Physiol Endocrinol Metab 274, E1034–E1039.
22. Frayn KN (2002). Adipose tissue as a buffer for daily lipid flux. Diabetologia 45, 1201–1210.
23. Hales CN & Barker DJ (2001). The thrifty phenotype hypothesis. Br Med Bull 60, 5–20.
24. Haslam DW & James WP (2005). Obesity. Lancet 366, 1197–1209.
25. Huang JY, Chiang MT & Chau LY (2013). Adipose overexpression of heme oxygenase-1 does not protect against high fat diet-induced insulin resistance in mice. PLoS ONE 8, e55369.
26. Irani BG, Dunn-Meynell AA & Levin BE (2007). Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 148, 310–316.
27. Kaneto A, Miki E & Kosaka K (1974). Effects of vagal stimulation on glucagon and insulin secretion. Endocrinology 95, 1005–1010.
28. Kral JG (1978). Vagotomy for treatment of severe obesity. Lancet 1(8059), 307–308.
29. Kral JG (1979). Vagotomy as a treatment for morbid obesity. Surg Clin North Am 59, 1131–1138.
30. Lalli CA, Pauli JR, Prada PO, Cintra DE, Ropelle ER, Velloso LA & Saad MJ (2008). Statin modulates insulin signaling and insulin resistance in liver and muscle of rats fed a high-fat diet. Metabolism 57, 57–65.
31. Leibowitz SF, Dourmashkin JT, Chang GQ, Hill JO, Gayles EC, Fried SK & Wang J (2004). Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle. Brain Res 1008, 168–178.
32. Lundbaek K (1962). Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br Med J 1(5291), 1507–1513.
33. Mann JI (2002). Diet and risk of coronary heart disease and type 2 diabetes. Lancet 360, 783–789.
34. Martinez JA (2000). Body-weight regulation: causes of obesity. Proc Nutr Soc 59, 337–345.
35. Park S, Hong SM, Lee JE & Sung SR (2007). Exercise improves glucose homeostasis that has been impaired by a high-fat diet by potentiating pancreatic β-cell function and mass through IRS2 in diabetic rats. J Appl Physiol 103, 1764–1771.
36. Prada PO, Pauli JR, Ropelle ER, Zecchin HG, Carvalheira JBC, Velloso LA & Saad MJA (2006). Selective modulation of the CAP/Cbl pathway in the adipose tissue of high fat diet treated rats. FEBS Lett 580, 4889–4894.
37. Raz I, Eldor R, Cernea S & Shafrir E (2005). Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Diabetes Metab Res Rev 21, 3–14.
38. Rogers P & Webb GP (1980). Estimation of body fat in normal and obese mice. Br J Nutr 43, 83–86.
39. Sclafani A (2001). Psychobiology of food preferences. Int J Obes Relat Metab Disord 25 (Suppl 5), S13–S16.
40. Scomparin DX, Gomes RM, Grassiolli S, Rinaldi W, Martins AG, de Oliveira JC, Gravena C & de Freitas Mathias PC (2009). Autonomic activity and glycemic homeostasis are maintained by precocious and low intensity training exercises in MSG-programmed obese mice. Endocrine 36, 510–517.
41. Scott AM, Atwater I & Rojas E (1981). A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia 21, 470–475.
42. Simonsson E & Ahrén B (1998). Potentiated β-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice. Eur J Pharmacol 350, 243–250.
43. Smith DK, Sarfeh J & Howard L (1983). Truncal vagotomy in hypothalamic obesity. Lancet 1(8337), 1330–1331.
44. Stearns AT, Balakrishnan A, Radmanesh A, Ashley SW, Rhoads DB & Tavakkolizadeh A (2012). Relative contributions of afferent vagal fibers to resistance to diet-induced obesity. Dig Dis Sci 57, 1281–1290.
45. van Abeelen AF, Elias SG, Bossuyt PM, Grobbee DE, van der Schouw YT, Roseboom TJ & Uiterwaal CS (2012). Famine exposure in the young and the risk of type 2 diabetes in adulthood. Diabetes 61, 2255–2260.
46. van de Wall EH, Pomp ER, Strubbe JH, Scheurink AJ & Koolhaas JM (2005). Deafferentation affects short-term but not long-term control of food intake. Physiol Behav 84, 659–667.
47. Vickers MH, Gluckman PD, Coveny AH, Hofman PL, Cutfield WS, Gertler A, Breier BH & Harris M (2005). Neonatal leptin treatment reverses developmental programming. Endocrinology 146, 4211–4216.
48. Woods SC, D’Alessio DA, Tso P, Rushing PA, Clegg DJ, Benoit SC, Gotoh K, Liu M & Seeley RJ (2004). Consumption of a high-fat diet alters the homeostatic regulation of energy balance. Physiol Behav 83, 573–578.